← Back to Search

Behavioural Intervention

Remote High-Intensity Interval Training for COVID-19 Recovery (REMM-HIIT-CoV Trial)

N/A
Recruiting
Led By Paul Wischmeyer, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years
Discharged or expected to be discharged directly home from the hospital (not to a skilled nursing facility, inpatient rehabilitation center, or long-term acute care hospital)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month follow-up
Awards & highlights

REMM-HIIT-CoV Trial Summary

This trial tests ways to help people who were critically ill with COVID-19 regain physical strength.

Who is the study for?
This trial is for adults over 18 who were hospitalized with COVID-19 and can walk on their own or with a cane. They should be going home directly from the hospital, not to another care facility, and must be able to exercise and use an iPhone for mobile health coaching.Check my eligibility
What is being tested?
The study tests a remote, mobile health-supported rehab program with high-intensity interval training (REMM-HIIT) in patients recovering from severe COVID-19. It's a randomized controlled trial involving 120 participants who complete at least one exercise session.See study design
What are the potential side effects?
While specific side effects are not listed, high-intensity interval training may cause muscle soreness, fatigue, or exacerbate underlying conditions if present. Participants will likely be monitored closely for any adverse reactions.

REMM-HIIT-CoV Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I will be going home directly after my hospital discharge.
Select...
I can walk by myself or with help like a cane before leaving the hospital.
Select...
I was hospitalized due to COVID-19.

REMM-HIIT-CoV Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cardiorespiratory fitness
Secondary outcome measures
Change in 30-sec sit to stand score
Change in 6 minute walk distance
Change in Duke Activity Status Index (DASI) Score
+21 more
Other outcome measures
Change in biomarkers of aging
Change in biomarkers of inflammation
DNA, Mitochondrial

REMM-HIIT-CoV Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: REmotely Monitored, Mobile health supported Multidomain Rehabilitation Program with HIITExperimental Treatment1 Intervention
Patients will receive our REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training Program (REMM-HIIT) with iWatch/iPhone.
Group II: Exercise education without personalized sessions or feedbackActive Control1 Intervention
Patients will receive an exercise handout and iWatch/iPhone. Patients return home to exercise without personalized instruction and coaching.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,355 Previous Clinical Trials
3,408,921 Total Patients Enrolled
49 Trials studying COVID-19
355,044 Patients Enrolled for COVID-19
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,953 Previous Clinical Trials
2,660,360 Total Patients Enrolled
12 Trials studying COVID-19
63,501 Patients Enrolled for COVID-19
Vanderbilt University Medical CenterOTHER
853 Previous Clinical Trials
670,948 Total Patients Enrolled
20 Trials studying COVID-19
42,778 Patients Enrolled for COVID-19

Media Library

REmotely Monitored, Mhealth supported High Intensity Interval Training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05218083 — N/A
COVID-19 Research Study Groups: REmotely Monitored, Mobile health supported Multidomain Rehabilitation Program with HIIT, Exercise education without personalized sessions or feedback
COVID-19 Clinical Trial 2023: REmotely Monitored, Mhealth supported High Intensity Interval Training Highlights & Side Effects. Trial Name: NCT05218083 — N/A
REmotely Monitored, Mhealth supported High Intensity Interval Training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05218083 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations are conducting this experiment?

"The locations accepting participants in this study include Duke University Health System in Durham, The Ohio State University Wexner Medical Center in Columbus, Vanderbilt University Medical Center and 4 other sites."

Answered by AI

Does this research endeavor presently admit participants?

"As reported on clinicaltrials.gov, this research initiative is looking for subjects to participate. It was initially advertised on February 21st 2023 and has been recently updated April 28th 2023."

Answered by AI

How many participants have been recruited to partake in this clinical experiment?

"Affirmative. Per the information on clinicaltrials.gov, this physician-led trial is actively recruiting participants since February 21st 2023 and was last updated on April 28th 2023. The study requires 120 individuals to be enrolled from 4 different medical facilities."

Answered by AI
~74 spots leftby Jan 2026